Deep Bio's AI Support for Cancer Diagnosis has been Designat

SEOUL, South Korea (PRWEB) July 25, 2022 -- Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics software, announced that its AI

Related Keywords

Seoul , Soult Ukpyolsi , South Korea , India , Korea , , Stanford Medical School , Korean Public Procurement Service , Harvard Dana Farber Cancer Institute , Bio Inc , Ministry Of Food , Innovative Product Designation Program , Samds In Vitro Diagnostics Software , Deep Bio , Prostate Pro , Innovative Product , Fast Track , Innovative Products , Public Procurement , Public Procurement Market , Sun Woo Kim , Whole Slide Image , Drug Safety , Cancers Journal , Digital Medicine , Vitro Diagnostics Software , Medical Device ,